Kymera Therapeutics, Inc. · NASDAQ:KYMR
Ridloff Elena sold 3,000 Kymera Therapeutics, Inc. shares (Form 4)
Traded May 11, 2026 · Filed May 11, 2026
On May 11, 2026, Ridloff Elena (Director) sold 3,000 Kymera Therapeutics, Inc. shares at US$87.00 for US$261K under a trading plan, leaving 0 shares. Filed May 11, 2026 (Form 4).
- Sold
- 3,000 shares
- Price
- US$87.00
- Value
- US$261K
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Option exercise | 3,000 | US$31.20 | 3,000 | Direct |
| May 11, 2026 | Common Stock | Sale | 3,000 | US$87.00 | 0 | Direct |
Source
Related
- Kymera Therapeutics, Inc.
- Ridloff Elena
- Kymera Therapeutics, Inc. shareholders
- Form 4 · Ridloff Elena · Apr 1, 2026
- Form 4 · Mainolfi Nello · Oct 1, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Sep 8, 2026
- Form 4 · Adams Brian · Sep 4, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Atlas Venture Fund X, L.P. · Aug 13, 2026